Article
Pristimerin suppresses the phenotypic switch of vascular smooth muscle cells in atherosclerosis through inhibiting the activation of JAK2/STAT3 pathway.
Molecular immunology - 1 Oct 2026
Liu Xiwen, Li Jiyu, Qu Lifeng, Qiao Tong
Abstract excerpt
AIM: The aim of our research was to investigate the potential effect of pristimerin (Pris) on atherosclerosis (AS), and clarify its underlying molecular mechanisms. METHODS: The effect of Pris on atherosclerotic lesions were assessed by using HE staining and Oil red O staining. Moreover, serum lipid profiles also detected using the commercial reagent kits. Inflammatory factors expression was determined employing...
Read the complete abstract on PubMedTopics
- Animals
- Janus Kinase 2
- STAT3 Transcription Factor
- Atherosclerosis
- Muscle, Smooth, Vascular
- Signal Transduction
